EA200800923A1 - Способ получения частицеобразующих композиций, содержащих конденсированные пирролокарбазолы - Google Patents

Способ получения частицеобразующих композиций, содержащих конденсированные пирролокарбазолы

Info

Publication number
EA200800923A1
EA200800923A1 EA200800923A EA200800923A EA200800923A1 EA 200800923 A1 EA200800923 A1 EA 200800923A1 EA 200800923 A EA200800923 A EA 200800923A EA 200800923 A EA200800923 A EA 200800923A EA 200800923 A1 EA200800923 A1 EA 200800923A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrocarbazoles
compositions containing
forming compositions
forming
containing condensed
Prior art date
Application number
EA200800923A
Other languages
English (en)
Other versions
EA014713B1 (ru
Inventor
Дэйв Дикесон
Брэдли Т. Макинтайр
Пиюш Р. Пейтел
Original Assignee
Сефалон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сефалон, Инк. filed Critical Сефалон, Инк.
Publication of EA200800923A1 publication Critical patent/EA200800923A1/ru
Publication of EA014713B1 publication Critical patent/EA014713B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

Раскрывается способ получения неводной и частицеобразующей композиции, содержащей конденсированный пирролокарбазол, по меньшей мере один органический растворитель, по меньшей мере одно поверхностно-активное вещество и необязательно антиоксидант.
EA200800923A 2003-11-20 2004-11-12 Способ получения частицеобразующих композиций, содержащих конденсированные пирролокарбазолы EA014713B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/718,077 US7795246B2 (en) 1998-08-06 2003-11-20 Particle-forming compositions containing fused pyrrolocarbazoles

Publications (2)

Publication Number Publication Date
EA200800923A1 true EA200800923A1 (ru) 2008-08-29
EA014713B1 EA014713B1 (ru) 2011-02-28

Family

ID=34633209

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200800923A EA014713B1 (ru) 2003-11-20 2004-11-12 Способ получения частицеобразующих композиций, содержащих конденсированные пирролокарбазолы
EA200601004A EA010293B1 (ru) 2003-11-20 2004-11-12 Частицеобразующие композиции, содержащие конденсированные пирролокарбазолы

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200601004A EA010293B1 (ru) 2003-11-20 2004-11-12 Частицеобразующие композиции, содержащие конденсированные пирролокарбазолы

Country Status (21)

Country Link
US (1) US7795246B2 (ru)
EP (1) EP1685137B1 (ru)
JP (1) JP2007512333A (ru)
KR (1) KR20070006674A (ru)
CN (1) CN1882594A (ru)
AT (1) ATE520697T1 (ru)
AU (1) AU2004292524A1 (ru)
BR (1) BRPI0416733A (ru)
CA (1) CA2545545A1 (ru)
EA (2) EA014713B1 (ru)
ES (1) ES2369365T3 (ru)
HK (1) HK1089772A1 (ru)
IL (1) IL175374A0 (ru)
IS (1) IS8486A (ru)
MX (1) MXPA06005714A (ru)
NO (1) NO20062381L (ru)
NZ (2) NZ577384A (ru)
SG (1) SG148175A1 (ru)
UA (1) UA87121C2 (ru)
WO (1) WO2005051958A2 (ru)
ZA (1) ZA200604072B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018000283A (es) 2015-07-07 2018-11-22 H Lundbeck As Inhibidores de fde9 con estructura basica de imidazotriazinona y estructura basica de imidazopirazinona en el tratamiento de enfermedades perifericas.

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62120388A (ja) 1985-11-19 1987-06-01 Meiji Seika Kaisha Ltd Ｓｆ−２３７０物質ハロゲン化誘導体とその製造法
JPS62155285A (ja) 1985-12-27 1987-07-10 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
JPS62155284A (ja) 1985-12-27 1987-07-10 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
JPH0826036B2 (ja) 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
JPH0826037B2 (ja) 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
EP0303697B1 (en) 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
JP2937446B2 (ja) 1990-09-14 1999-08-23 株式会社資生堂 白髪防止黒化剤
CA2112799A1 (en) 1991-07-03 1993-01-21 Stephen P. Squinto Method and assay system for neurotrophin activity
WO1993008809A1 (en) 1991-11-08 1993-05-13 The University Of Southern California Compositions containing k-252 compounds for potentiation of neurotrophin activity
US5621101A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
US5621100A (en) * 1992-07-24 1997-04-15 Cephalon, Inc. K-252a derivatives for treatment of neurological disorders
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders
CA2163904C (en) * 1993-05-28 2000-01-25 Craig A. Dionne Use of indolocarbazole derivatives to treat a pathological condition of the prostate
US5468872A (en) * 1993-09-16 1995-11-21 Cephalon, Inc. K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders
GB9325395D0 (en) 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733358A3 (de) * 1995-03-21 1998-05-20 Novartis AG Intravenös applizierbare Nanosuspensionen
JPH08301762A (ja) * 1995-05-12 1996-11-19 Teijin Ltd 肺癌治療剤
JPH08333245A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
ES2296311T3 (es) 1996-06-18 2008-04-16 Kyowa Hakko Kogyo Co., Ltd. Preparaciones de liposomas de derivados de indolo carbazol.
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
JP4593074B2 (ja) * 2000-10-11 2010-12-08 セフアロン・インコーポレーテツド モダフィニル化合物含有組成物

Also Published As

Publication number Publication date
MXPA06005714A (es) 2006-08-17
IS8486A (is) 2006-05-26
NZ547225A (en) 2009-06-26
CA2545545A1 (en) 2005-06-09
ATE520697T1 (de) 2011-09-15
NZ577384A (en) 2010-12-24
ES2369365T3 (es) 2011-11-29
EA010293B1 (ru) 2008-08-29
EA014713B1 (ru) 2011-02-28
US7795246B2 (en) 2010-09-14
AU2004292524A1 (en) 2005-06-09
EP1685137A2 (en) 2006-08-02
EA200601004A1 (ru) 2006-10-27
IL175374A0 (en) 2006-09-05
SG148175A1 (en) 2008-12-31
EP1685137B1 (en) 2011-08-17
WO2005051958A3 (en) 2006-01-12
WO2005051958A2 (en) 2005-06-09
JP2007512333A (ja) 2007-05-17
US20040220176A1 (en) 2004-11-04
HK1089772A1 (en) 2006-12-08
ZA200604072B (en) 2007-09-26
UA87121C2 (ru) 2009-06-25
CN1882594A (zh) 2006-12-20
KR20070006674A (ko) 2007-01-11
NO20062381L (no) 2006-06-09
BRPI0416733A (pt) 2007-01-16

Similar Documents

Publication Publication Date Title
CY1107855T1 (el) Συνθεσεις που σχηματιζουν σωματιδια οι οποιες περιεχουν τηγμενα πυρρολοκαρβαζολια
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
EA200602093A1 (ru) Стабилизирующие растворы для субмикронных частиц, способы их получения и способы стабилизации субмикронных частиц
BRPI0517417A (pt) composto, uso de um composto ou um éster do mesmo,composição farmacêutica, e, método para a triagem de ligandos do receptor de prostanóide seletivos
EA200500388A1 (ru) Способ получения сухих порошковых композиций для ингаляции
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
NO20031754D0 (no) Fremgangsmåte for fremstilling av mesylater av piperzinderivater
EA200800923A1 (ru) Способ получения частицеобразующих композиций, содержащих конденсированные пирролокарбазолы
EA200300988A1 (ru) Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина
EA200300448A1 (ru) Композиции, включающие соединения модафинила
CY1106712T1 (el) Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
FR2817858B1 (fr) Procede pour l'inertage d'une cendre, pouzzolane artificielle obtenue au moyen dudit procede
EA200501829A1 (ru) Способ получения непептидных замещённых спиробензоазепиновых производных
NO20052392L (no) Fremgangsmate for fremstilling av acetylenforbindelser.
AR034313A1 (es) Utilizacion de derivados de piridoindolona para la preparacion de medicamentos
CY1115106T1 (el) Ενωσεις πυρρολο[2,3-d]πυριμιδινης
AR048275A1 (es) 4-ciano-n-{(2r)-2[4-(2,3-dihidro-benzo[1,4]dioxin-5-il)-piperazin-1-il]-propil}-n-piridin-2-il-benzamida, formas de dosificacion y composiciones farmaceuticas
NO20013317D0 (no) Fremgangsmåte for fremstilling av metalliske materialer for anvendelse som elektroder
NO20013357L (no) Fremgangsmåte for fremstilling av metalliske materialer for anvendelse som elektroder
EA200501535A1 (ru) Способ получения имидазопиридин-8-онов
WO2007129269A3 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU